Nuveen
ERAS icon

Nuveen’s Erasca ERAS Stock Holding History

Nuveen’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.7M Buy
1,841,735
+1,298,714
+239% +$18.6M 0.01% 942
2026
Q1 		$8.79M Buy
543,021
+118,308
+28% +$1.4M ﹤0.01% 1627
2025
Q4 		$1.58M Sell
424,713
-25,343
-6% -$71.3K ﹤0.01% 2393
2025
Q3 		$981K Hold
450,056
– – ﹤0.01% 2632
2025
Q2 		$572K Sell
450,056
-33,527
-7% -$44.9K ﹤0.01% 2838
2025
Q1 		$663K Sell
483,583
-72,121
-13% -$124K ﹤0.01% 2806
2024
Q4 		$1.39M Buy
555,704
+72,121
+15% +$198K ﹤0.01% 2542
2024
Q3 		$1.32M Sell
483,583
-689,023
-59% -$1.94M ﹤0.01% 2635
2024
Q2 		$2.77M Buy
1,172,606
+482,405
+70% +$1.04M ﹤0.01% 2221
2024
Q1 		$1.42M Sell
690,201
-509,751
-42% -$1.02M ﹤0.01% 2555
2023
Q4 		$2.56M Buy
1,199,952
+2,012
+0.2% +$4.24K ﹤0.01% 2298
2023
Q3 		$2.36M Buy
1,197,940
+18,228
+2% +$46.7K ﹤0.01% 2225
2023
Q2 		$3.26M Buy
1,179,712
+468,305
+66% +$1.33M ﹤0.01% 2124
2023
Q1 		$2.14M Buy
711,407
+351,307
+98% +$1.28M ﹤0.01% 2304
2022
Q4 		$1.55M Buy
360,100
+87,419
+32% +$593K ﹤0.01% 2490
2022
Q3 		$2.13M Sell
272,681
-7,189
-3% -$57.9K ﹤0.01% 2370
2022
Q2 		$1.56M Buy
279,870
+36,842
+15% +$241K ﹤0.01% 2568
2022
Q1 		$2.4M Buy
243,028
+213,389
+720% +$2.47M ﹤0.01% 2419
2021
Q4 		$384K Sell
29,639
-13,138
-31% -$225K ﹤0.01% 3129
2021
Q3 		$908K Buy
+42,777
New +$882K ﹤0.01% 3019

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Nuveen's ERAS Position: Q2 2026 in Review

Nuveen increased its Erasca (ERAS) stake by 239% in Q2 2026, buying an estimated $18.6M and bringing the position to 1,841,735 shares worth $33.7M. The position accounts for 0.01% of the portfolio, ranked #942.

Nuveen first reported a position in ERAS in Q3 2021 and has held it in 20 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Nuveen held 1,841,735 shares of Erasca worth $33.7M as of Q2 2026.
  • Nuveen bought 1,298,714 Erasca shares in Q2 2026, an estimated $18.6M.
  • Erasca made up 0.01% of Nuveen's portfolio in Q2 2026, its #942 holding.
  • Nuveen first reported a position in Erasca in Q3 2021 and has held it in 20 quarters since.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.